Gilead Sciences, established over 35 years ago, is dedicated to transforming the impossible into achievable healthcare solutions, creating a healthier world for everyone. Recognized for its groundbreaking approach, Gilead develops innovative and transformative therapies targeting serious diseases, including HIV, viral hepatitis, and cancer. Their mission revolves around revolutionizing patient care through ambitious research programs aimed at discovering and enhancing access to cutting-edge treatments.

The company fosters sustainable practices and collaborates with global organizations and associations to improve medication accessibility. Gilead is also committed to raising awareness about health issues, evident through initiatives like HIV and HCV education campaigns, which encourage dialogue between healthcare providers and patients while promoting understanding of disease management and testing importance.

Their offerings extend to a wealth of resources for healthcare professionals, ensuring that clinicians have the support needed to optimize patient care. By continuously pushing the boundaries of innovation, Gilead Sciences remains at the forefront of addressing unmet health needs globally.